<DOC>
	<DOCNO>NCT02183480</DOCNO>
	<brief_summary>Study ass pharmacokinetics dose proportionality 1 mg , 2.5 mg 5 mg tablet linagliptin</brief_summary>
	<brief_title>Dose Proportionality Different Dose Strengths Linagliptin Tablets After Oral Administration Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Healthy male female volunteer accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( Blood Pressure ( BP ) , Pulse Rate ( PR ) ) , 12lead ECG ( electrocardiogram ) , clinical laboratory test Age 18 55 year ( inclusive ) BMI ( Body Mass Index ) 18.5 29.9 kg/m2 ( inclusive ) Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation Any finding medical examination ( include BP , PR ECG ) deviate normal clinical relevance . Repeated measurement systolic blood pressure great 140 mmHg diastolic blood pressure great 90 mmHg Any evidence clinically relevant concomitant disease Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History relevant allergy/hypersensitivity ( include allergy drug excipients ) Intake drug within one month le 10 halflives respective drug prior first study drug administration except relevant interaction rule Participation another trial investigational drug within two month prior administration trial Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Alcohol abuse ( average consumption 20 g/day female 30 g/day male ) Drug abuse Blood donation ( 100 mL within four week prior administration trial ) Any laboratory value outside reference range clinical relevance Inability comply dietary regimen trial site For female subject : Positive pregnancy test , pregnancy plan become pregnant study within 2 month study completion No adequate contraception study 1 month study completion , i.e . follow : implant , injectables , combine oral contraceptive , IUD ( intrauterine device ) , sexual abstinence least 1 month prior enrolment , vasectomised partner ( vasectomy perform least 1 year prior enrolment ) , surgical sterilisation ( include hysterectomy ) . Females , vasectomise partner , sexually abstinent surgically sterile ask use additional barrier method ( e.g . condom , diaphragm spermicide ) Lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>